We demonstrated that the non-traditional cardiovascular risk factors, the TG/HDL ratio, IL-2, IL-6, IL-17A, and INF-γ, were significantly increased in children with MetS than those without MetS, and may therefore be used as biomarkers to predict future cardiovascular disease. This evidence concerns the gene IL2 and metabolic syndrome.